P38 kinase inhibitors
US8119798B2 · kind B2 · utility
1Cited by
0References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 1, 2007 |
| Grant date | Feb 21, 2012 |
| Priority date | — |
| Expiry date | Aug 1, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC40B40/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) and (II) are disclosed, as well as methods for their identification, their preparation, pharmaceutical compositions containing them, and their use in treating disease. The compounds inhibit the production of TNF-alpha and interleukins (IL) by the inhibition of p38 kinase. They are useful in the treatment of inflammation and arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.